Serum androgen levels and testicular structure during pubertal maturation in male subjects with epilepsy

Epilepsia

Volumn 45, Issue 7, 2004, Pages 769-776

  Mikkonen, Kirsi ^a   Tapanainen, Päivi ^a   Pakarinen, Arto J ^a   Päivänsalo, Markku ^a   Isojärvi, Jouko I T ^a   Vainionpää, Leena K ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Antiepileptic drugs; Children; Epilepsy; Hormone; Testicles

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CARBAMAZEPINE; FOLLITROPIN; INHIBIN B; LAMOTRIGINE; LUTEINIZING HORMONE; OXCARBAZEPINE; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; VALPROIC ACID;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BLOOD VOLUME; CONCENTRATION RESPONSE; CONTROLLED STUDY; ECHOGRAPHY; ENDOCRINE FUNCTION; EPILEPSY; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREPUBERTY; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; TESTIS;

ADOLESCENT; ADULT; ANDROGENS; ANDROSTENEDIONE; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; EPILEPSY; HUMANS; MALE; PUBERTY; REGRESSION ANALYSIS; SEX HORMONE-BINDING GLOBULIN; TESTIS; TESTOSTERONE; TRIAZINES; VALPROIC ACID;

EID: 3042856688     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0013-9580.2004.04604.x     Document Type: Article

References (36)

1. Isojärvi JI, Laatikainen TJ, Pakarinen AJ, et al. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993;329:1383-8.
2. Bauer J, Isojärvi JI, Herzog AG, et al. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatry 2002;73:121-5.
3. Morrell MJ, Isojärvi J, Taylor AE, et al. Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy. Epilepsy Res 2003;54:189-99.
4. Isojärvi JI, Tauboll E, Pakarinen AJ, et al. Altered ovarian function and cardiovascular risk factors in valproate-treated women. Am J Med 2001;111:290-6.
5. Stephen LJ, Kwan P, Shapiro D, et al. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy . Epilepsia 2001;42:1002-6.
6. Morrell MJ, Giudice L, Flynn KL, et al. Predictors of ovulatory failure in women with epilepsy. Ann Neurol 2002;52:704-11.
7. Vainionpää LK, Rättyä J, Knip M, et al. Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Ann Neurol 1999;45:444-50.
8. Mikkonen K, Vainionpää LK, Pakarinen AJ, et al. Long-term reproductive endocrine health in young women with epilepsy during puberty. Neurology 2004;62:445-50.
9. Murialdo G, Galimberti CA, Gianelli MV, et al. Effects of valproate, phenobarbital, and carbamazepine on sex steroid setup in women with epilepsy. Clin Neuropharmacol 1998;21:52-8.
10. Rättyä J, Turkka J, Pakarinen AJ, et al. Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy. Neurology 2001;56:31-6.
11. Isojärvi JIT, Löfgren E, Juntunen KST, et al. Effect of epilepsy and anti-epileptic drugs on male reproductive health. Neurology 2004;62:247-53.
12. Macphee GJ, Larkin JG, Butler E, et al. Circulating hormones and pituitary responsiveness in young epileptic men receiving long-term antiepileptic medication. Epilepsia 1988;29:468-75.
13. Isojärvi JI, Pakarinen AJ, Ylipalosaari PJ, et al. Serum hormones in male epileptic patients receiving anticonvulsant medication. Arch Neurol 1990;47:670-6.
14. Isojärvi JI, Repo M, Pakarinen AJ, et al. Carbamazepine, phenytoin, sex hormones, and sexual function in men with epilepsy. Epilepsia 1995;36:366-70.
15. Rättyä J, Pakarinen AJ, Knip M, et al. Early hormonal changes during valproate or carbamazepine treatment: a 3-month study. Neurology 2001;57:440-4.
16. Chen SS, Shen MR, Chen TJ, et al. Effects of antiepileptic drugs on sperm motility of normal controls and epileptic patients with long-term therapy. Epilepsia 1992;33:149-53.
17. Roste LS, Tauboll E, Haugen TB, et al. Alterations in semen parameters in men with epilepsy treated with valproate or carbamazepine monotherapy. Eur J Neurol 2003;10:501-6.
18. El Khayat HA, Shatla HM, Ali GK, et al. Physical and hormonal profile of male sexual development in epilepsy. Epilepsia 2003;44:447-52.
19. Yerby MS, McCoy GB. Male infertility: possible association with valproate exposure. Epilepsia 1999;40:520-1.
20. Sveberg RL, Tauboll E, Berner A, et al. Morphological changes in the testis after long-term valproate treatment in male Wistar rats. Seizure 2001;10:559-65.
21. Isojärvi JI, Laatikainen TJ, Knip M, et al. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 1996;39:579-84.
22. Biton V, Mirza W, Montouris G, et al. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology 2001;56:172-7.
23. Verrotti A, Basciani F, Morresi S, et al. Serum sex hormone levels in young male patients with epilepsy receiving carbamazepine and valproic acid and after their withdrawal. Eur J Pediatr 2000;159:871-2.
24. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
25. Sorva R, Lankinen S, Tolppanen EM, et al. Variation of growth in height and weight of children, II: after infancy. Acta Paediatr Scand 1990;79:498-506.
26. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976;51:170-9.
27. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. Stanford, CA: Stanford University Press, 1959.
28. Keränen T, Jolkkonen J, Klosterskov-Jensen P, et al. Single-dose kinetics of oxcarbazepine after treatment with cimetidine or erythromycin. Epilepsia 1990;31:641.
29. Fraser AD, MacNeil W, Isner AF, et al. Lamotrigine analysis in serum by high-performance liquid chromatography. Ther Drug Monit 1995;17:174-8.
30. Balaguer Martinez JV, Lopez Garcia MJ, Andres CM, et al. [Effects of valproate on sexual development]. An Pediatr (Barc) 2003;58:443-8.
31. Bilo L, Meo R, Valentino R, et al. Abnormal pattern of luteinizing hormone pulsatility in women with epilepsy. Fertil Steril 1991;55:705-11.
32. Merke DP, Bornstein SR, Avila NA, et al. NIH conference: future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Ann Intern Med 2002;136:320-34.
33. Isojärvi JI, Pakarinen AJ, Myllylä VV. Effects of carbamazepine on the hypothalamic-pituitary-gonadal axis in male patients with epilepsy: a prospective study. Epilepsia 1989;30:446-52.
34. Perucca E, Hedges A, Makki KA, et al. A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients. Br J Clin Pharmacol 1984;18:401-10.
35. Connell JM, Rapeport WG, Beastall GH, et al. Changes in circulating androgens during short term carbamazepine therapy. Br J Clin Pharmacol 1984;17:347-51.
36. Isojärvi JI, Pakarinen AJ, Rautio A, et al. Serum sex hormone levels after replacing carbamazepine with oxcarbazepine. Eur J Clin Pharmacol 1995;47:461-4.